InvestorsHub Logo
Followers 13
Posts 3218
Boards Moderated 0
Alias Born 04/26/2007

Re: None

Wednesday, 09/01/2021 6:10:21 PM

Wednesday, September 01, 2021 6:10:21 PM

Post# of 40492
8/30/21 Update P2: 52ppl INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Actual Study Start Date :
May 31, 2018
Estimated Study Completion Date :
December 30, 2021
21 US study locations

OS30 is Nov 2021. OS24 was May 2021.

https://clinicaltrials.gov/ct2/history/NCT03491683?A=28&B=29&C=merged#StudyPageTop
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News